Status:
ACTIVE_NOT_RECRUITING
Therapeutic Intervention of Eriomin Associated with Metformin in the Control of Hyperglycemia in Pre-Diabetic Patients
Lead Sponsor:
Thais Cesar
Collaborating Sponsors:
Ingredients by Nature TM
Conditions:
Pre-diabetes
Eligibility:
All Genders
35-65 years
Phase:
NA
Brief Summary
Citrus bioflavonoids, such as eriocitrin, hesperidin and naringin, have been shown improved hyperglycemia, insulin resistance and systemic inflammation, related to the development of type 2 diabetes. ...
Detailed Description
Recent evidence shows that bioflavonoids from citrus fruits and herbs can reduce hyperglycemia, dyslipidemia, insulin resistance and the systemic inflammatory process related to type 2 diabetes (T2D)....
Eligibility Criteria
Inclusion
- Glycemia of 6.1 to 7.0 mmol / L
- Glycated hemoglobin with values between 5.7 and 6.4%
Exclusion
- use of drugs, vitamins and dietary supplements, alcohol consumption (\> 20 g alcohol/d), and intense physical activity (\> 5 hours/week).
- History of cardiovascular disease, diabetes mellitus, liver, kidney or pancreatic disease
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06005142
Start Date
January 15 2024
End Date
December 30 2024
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Estudos e Praticas em Nutrição (CEPRAN)
Botucatú, São Paulo, Brazil, 18618-689